openPR Logo
Press release

Investigation announced for Investors who lost money with shares of QidelOrtho Corporation (NASDAQ: QDEL)

02-22-2024 07:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in QuidelOrtho Corporation (NASDAQ: QDEL) shares over potential securities laws violations.

An investigation for investors in QuidelOrtho Corporation (NASDAQ: QDEL) shares over potential securities laws violations.

An investigation was announced over potential securities laws violations by QuidelOrtho Corporation in connection with certain statements.

Investors who purchased shares of QuidelOrtho Corporation (NASDAQ: QDEL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of QuidelOrtho Corporation (NASDAQ: QDEL) concerning whether a series of statements by QuidelOrtho Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Diego, CA based QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. QuidelOrtho Corporation reported that its annual Total Revenue rose from over $1.69 billion in 2021 to over $3.26 billion in 2022, and that its Net Income declined from $704.2 million in 2021 to $548.7 million in 2022.

On February 13, 2024, QuidelOrtho Corporation reported fourth quarter and full-year 2023 financial results. GAAP net income for Q4 2023 was $7 million, with diluted earnings per share (EPS) of $0.10, a decrease from $30.3 million and $0.45 EPS in the prior year period. Revenue for the quarter was $742.6M, missing estimates by $44.86M.

Then the Board of Directors terminated Douglas Bryant, President and CEO. Mr. Bryant has also resigned from the Board, both effective February 21, 2024.

Shares of QuidelOrtho Corporation (NASDAQ: QDEL) declined from $75.83 per share on December 22, 2023, to $41.75 per share on February 16, 2024.

Those who purchased shares of QuidelOrtho Corporation (NASDAQ: QDEL) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors who lost money with shares of QidelOrtho Corporation (NASDAQ: QDEL) here

News-ID: 3395950 • Views:

More Releases from Shareholders Foundation

Deadline on June 10th coming up in Lawsuit for Investors in shares of Ocugen, Inc. (NASDAQ: OCGN)
Deadline on June 10th coming up in Lawsuit for Investors in shares of Ocugen, In …
A deadline is coming up on June 10, 2024 in the lawsuit filed for certain investors of Ocugen, Inc. (NASDAQ: OCGN) over alleged securities laws violations by Ocugen, Inc. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN ) have certain options and there are strict and short deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potential Wrongdoing
Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potent …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of FMC Corporation. Investors who are current long term investors in FMC Corporation (NYSE: FMC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: FMC stocks follows a lawsuit filed against FMC Corporation over
Investigation announced for Long-Term Investors who lost money with Advance Auto Parts, Inc. (NYSE: AAP)
Investigation announced for Long-Term Investors who lost money with Advance Auto …
An investigation was announced for long-term investors in shares of Advance Auto Parts, Inc. (NYSE: AAP) concerning potential breaches of fiduciary duties by certain directors of Advance Auto Parts, Inc. Investors who are current long term investors in Advance Auto Parts, Inc. (NYSE: AAP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long
Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) over potential Wrongdoing
Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Treace Medical Concepts, Inc. Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Treace Medical Concepts, Inc. directors breached their fiduciary duties and caused damage to the company and its

All 5 Releases